08:49 AM EDT, 05/09/2024 (MT Newswires) -- Intellia Therapeutics ( NTLA ) reported a Q1 net loss Thursday of $1.12 per diluted share, narrowing from a net loss of $1.17 a year earlier.

Analysts polled by Capital IQ expected a loss of $1.37.

Collaboration revenue for the quarter ended March 31 was $28.9 million, up from $12.6 million a year earlier.

Analysts surveyed by Capital IQ expected revenue of $9.1 million.

Price: 23.20, Change: +0.20, Percent Change: +0.87